LAVINIA P MIDDLETON to Disease-Free Survival
This is a "connection" page, showing publications LAVINIA P MIDDLETON has written about Disease-Free Survival.
Connection Strength
0.128
-
Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ. Arch Pathol Lab Med. 2011 Jun; 135(6):737-43.
Score: 0.042
-
Expression of ERalpha and ERbeta in lobular carcinoma in situ. Histopathology. 2007 Jun; 50(7):875-80.
Score: 0.032
-
A phase 2 study of capecitabine and concomitant radiation in women with advanced breast cancer. Int J Radiat Oncol Biol Phys. 2017 11 15; 99(4):777-783.
Score: 0.016
-
Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. Hum Pathol. 2011 Aug; 42(8):1169-77.
Score: 0.010
-
Glutathione-s-transferase-pi expression in early breast cancer: association with outcome and response to chemotherapy. Cancer Invest. 2010 Jun; 28(5):554-9.
Score: 0.010
-
Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer. Cancer. 2009 Apr 15; 115(8):1605-12.
Score: 0.009
-
Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy. J Clin Oncol. 2006 Nov 01; 24(31):4971-5.
Score: 0.008